We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
Turnover
18.52%
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
-1.67%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$80.5B
AUM Growth
-$3.46B
(-4.1%)
Cap. Flow
-$1.21B
Cap. Flow
% of AUM
-1.5%
Top 10 Holdings %
Top 10 Hldgs %
13.64%
Holding
817
New
51
Increased
266
Reduced
358
Closed
117
Avg Time Held
3.4
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$499M |
| 2 |
Fidelity National Information Services
FIS
|
+$462M |
| 3 |
Honeywell
HON
|
+$367M |
| 4 |
Lennar Class A
LEN
|
+$321M |
| 5 |
Extra Space Storage
EXR
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sanofi
SNY
|
+$486M |
| 2 |
Global Payments
GPN
|
+$421M |
| 3 |
Eaton
ETN
|
+$415M |
| 4 |
Dell
DELL
|
+$391M |
| 5 |
Howmet Aerospace
HWM
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.82% |
| 2 | Technology | 16.67% |
| 3 | Industrials | 16.22% |
| 4 | Healthcare | 11.1% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
576
Heritage Financial
HFWA
$1.13B
| $1.08M | ﹤0.01% |
59,860
-52,583
| -47% | -$944K |
2013 Q2
44 quarters
|
|
577
TETRA Technologies
TTI
$788M
| $1.08M | ﹤0.01% |
311,253
+263,960
| +558% | +$1.05M |
2023 Q2
4 quarters
|
|
578
Babcock & Wilcox
BW
$688M
| $1.07M | ﹤0.01% |
734,489
+415,619
| +130% | +$499K |
2023 Q4
2 quarters
|
|
579
Warrior Met Coal
HCC
$4.75B
| $1.06M | ﹤0.01% |
16,877
+4,324
| +34% | +$280K |
2021 Q1
13 quarters
|
|
580
Turning Point Brands
TPB
$1.26B
| $1.06M | ﹤0.01% |
32,909
| – | – |
2024 Q1
1 quarter
|
|
581
Euroseas
ESEA
$467M
| $1.02M | ﹤0.01% |
35,804
| – | – |
2022 Q2
8 quarters
|
|
582
Radiant Logistics
RLGT
$422M
| $1.01M | ﹤0.01% |
176,780
+130,606
| +283% | +$680K |
2017 Q4
26 quarters
|
|
583
BrightView Holdings
BV
$976M
| $987K | ﹤0.01% |
+74,247
| New | +$946K |
2024 Q2
0 quarters
|
|
584
Gentherm
THRM
$1.58B
| $980K | ﹤0.01% |
19,868
+9,415
| +90% | +$487K |
2023 Q4
2 quarters
|
|
585
CTO Realty Growth
CTO
$770M
| $978K | ﹤0.01% |
56,037
+30,327
| +118% | +$525K |
2017 Q4
26 quarters
|
|
586
Esquire Financial Holdings
ESQ
$1.44B
| $955K | ﹤0.01% |
20,054
+11,508
| +135% | +$540K |
2023 Q1
5 quarters
|
|
587
Unitil
UTL
$986M
| $951K | ﹤0.01% |
18,364
+12,483
| +212% | +$642K |
2022 Q3
7 quarters
|
|
588
NMI Holdings
NMIH
$3.06B
| $945K | ﹤0.01% |
27,774
+14,758
| +113% | +$475K |
2018 Q2
24 quarters
|
|
589
Pennant Group
PNTG
$1.46B
| $942K | ﹤0.01% |
40,642
-75,040
| -65% | -$1.64M |
2022 Q3
7 quarters
|
|
590
Tiptree Inc
TIPT
$613M
| $942K | ﹤0.01% |
57,153
+30,369
| +113% | +$508K |
2019 Q4
18 quarters
|
|
591
Transocean
RIG
$6.28B
| $938K | ﹤0.01% |
+175,399
| New | +$1.01M |
2024 Q2
0 quarters
|
|
592
Orthofix Medical
OFIX
$382M
| $931K | ﹤0.01% |
70,187
+37,294
| +113% | +$511K |
2023 Q1
5 quarters
|
|
593
NWPX Infrastructure Inc
NWPX
$941M
| $927K | ﹤0.01% |
27,280
+15,753
| +137% | +$535K |
2021 Q1
13 quarters
|
|
594
Capital Bancorp
CBNK
$645M
| $921K | ﹤0.01% |
44,945
+23,882
| +113% | +$479K |
2021 Q2
12 quarters
|
|
595
Ranpak Holdings
PACK
$297M
| $919K | ﹤0.01% |
142,858
+75,908
| +113% | +$513K |
2022 Q4
6 quarters
|
|
596
Teva Pharmaceutical Industries Limited
TEVA
$48.4B
| $915K | ﹤0.01% |
56,280
+27,224
| +94% | +$419K |
2023 Q4
2 quarters
|
|
597
Jazz Pharmaceuticals
JAZZ
$13.6B
| $914K | ﹤0.01% |
8,566
-628
| -7% | -$69K |
2017 Q4
26 quarters
|
|
598
Braskem
BAK
$661M
| $908K | ﹤0.01% |
+140,791
| New | +$1.12M |
2024 Q2
0 quarters
|
|
599
Covenant Logistics
CVLG
$780M
| $907K | ﹤0.01% |
36,812
-1,740
| -5% | -$40.4K |
2024 Q1
1 quarter
|
|
600
Silicon Motion
SIMO
$7.16B
| $904K | ﹤0.01% |
11,160
+3,264
| +41% | +$255K |
2023 Q4
2 quarters
|
|
Similar funds
Boston Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Boston Partners held 817 positions worth $80.5B, down 4.1% from $84B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Boston Partners's Q2 2024 filing shows 51 new, 266 increased, 358 reduced and 117 closed positions. Its largest new stake was Honeywell: 1,930,615 shares worth $389M. The largest sale was Sanofi, an estimated $486M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
- Boston Partners's largest Q2 2024 buy was Honeywell: 1,930,615 shares worth $389M.
- Boston Partners added most to AbbVie in Q2 2024, an estimated $499M increase.
- Boston Partners's biggest Q2 2024 reduction was Sanofi, cutting an estimated $486M.
- Boston Partners fully exited Globe Life in Q2 2024, selling an estimated $243M.
- Boston Partners's ten largest holdings make up 14% of its $80.5B portfolio in Q2 2024.
- Boston Partners opened 51 new positions and closed 117 in Q2 2024.
- Boston Partners's portfolio value fell 4.1% quarter-over-quarter to $80.5B.
Based on Boston Partners's 13F filing for Q2 2024, filed 14 Aug 2024.